Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

222 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Ultrasensitive prostate-specific antigen level as a predictor of biochemical progression after robot-assisted radical prostatectomy: Towards risk adapted follow-up.
Grivas N, de Bruin D, Barwari K, van Muilekom E, Tillier C, van Leeuwen PJ, Wit E, Kroese W, van der Poel H. Grivas N, et al. Among authors: van muilekom e, van leeuwen pj, van der poel h. J Clin Lab Anal. 2019 Feb;33(2):e22693. doi: 10.1002/jcla.22693. Epub 2018 Oct 26. J Clin Lab Anal. 2019. PMID: 30365194 Free PMC article.
Prostate-Specific Membrane Antigen PET/CT Combined with Sentinel Node Biopsy for Primary Lymph Node Staging in Prostate Cancer.
Hinsenveld FJ, Wit EMK, van Leeuwen PJ, Brouwer OR, Donswijk ML, Tillier CN, Vegt E, van Muilekom E, van Oosterom MN, van Leeuwen FWB, van der Poel HG. Hinsenveld FJ, et al. Among authors: van leeuwen fwb, van muilekom e, van leeuwen pj, van oosterom mn, van der poel hg. J Nucl Med. 2020 Apr;61(4):540-545. doi: 10.2967/jnumed.119.232199. Epub 2019 Sep 27. J Nucl Med. 2020. PMID: 31562222 Free article.
Prediction of early (30-day) and late (30-90-day) mortality after radical cystectomy in a comprehensive cancer centre over two decades.
Korbee ML, Voskuilen CS, Hendricksen K, Mayr R, Wit EM, van Leeuwen PJ, Horenblas S, Meinhardt W, Burger M, Bex A, van der Poel HG, van Rhijn BWG. Korbee ML, et al. Among authors: van rhijn bwg, van leeuwen pj, van der poel hg. World J Urol. 2020 Sep;38(9):2197-2205. doi: 10.1007/s00345-019-03011-2. Epub 2019 Nov 14. World J Urol. 2020. PMID: 31728672
Detection of Recurrent Prostate Cancer Using Prostate-specific Membrane Antigen Positron Emission Tomography in Patients not Meeting the Phoenix Criteria for Biochemical Recurrence After Curative Radiotherapy.
Jansen BHE, van Leeuwen PJ, Wondergem M, van der Sluis TM, Nieuwenhuijzen JA, Knol RJJ, van Moorselaar RJA, van der Poel HG, Oprea-Lager DE, Vis AN. Jansen BHE, et al. Among authors: van der sluis tm, van leeuwen pj, van moorselaar rja, van der poel hg. Eur Urol Oncol. 2021 Oct;4(5):821-825. doi: 10.1016/j.euo.2020.01.002. Epub 2020 Feb 20. Eur Urol Oncol. 2021. PMID: 32088155
Prostate Specific Membrane Antigen Positron Emission Tomography/Computerized Tomography in the Evaluation of Initial Response in Candidates Who Underwent Salvage Radiation Therapy after Radical Prostatectomy for Prostate Cancer.
Meijer D, Luiting HB, van Leeuwen PJ, Remmers S, Jansen BHE, Bodar YJL, Witteveen T, Schaake EE, van der Poel HG, Wondergem M, Busstra MB, Nieuwenhuijzen JA, Meijnen P, Brabander T, van Moorselaar RJA, Hendrikse NH, Oprea-Lager DE, Roobol MJ, Vis AN. Meijer D, et al. Among authors: van leeuwen pj, van moorselaar rja, van der poel hg. J Urol. 2021 Apr;205(4):1100-1109. doi: 10.1097/JU.0000000000001437. Epub 2020 Nov 18. J Urol. 2021. PMID: 33207138
Reply by Authors.
Meijer D, Luiting HB, van Leeuwen PJ, Remmers S, Jansen BHE, Bodar YJL, Witteveen T, Schaake EE, van der Poel HG, Wondergem M, Busstra MB, Nieuwenhuijzen JA, Meijnen P, Brabander T, van Moorselaar RJA, Hendrikse NH, Oprea-Lager DE, Roobol MJ, Vis AN. Meijer D, et al. Among authors: van leeuwen pj, van moorselaar rja, van der poel hg. J Urol. 2021 Apr;205(4):1108-1109. doi: 10.1097/JU.0000000000001437.02. Epub 2021 Jan 25. J Urol. 2021. PMID: 33493004 No abstract available.
Management impact of 18F-DCFPyL PET/CT in hormone-sensitive prostate cancer patients with biochemical recurrence after definitive treatment: a multicenter retrospective study.
Meijer D, van Leeuwen PJ, Oosterholt PMJ, Bodar YJL, van der Poel HG, Hendrikse NH, Donswijk ML, Wondergem M, Vellekoop AE, van Moorselaar RJA, Nieuwenhuijzen JA, Oprea-Lager DE, Vis AN. Meijer D, et al. Among authors: van leeuwen pj, van moorselaar rja, van der poel hg. Eur J Nucl Med Mol Imaging. 2021 Aug;48(9):2960-2969. doi: 10.1007/s00259-021-05222-5. Epub 2021 Feb 5. Eur J Nucl Med Mol Imaging. 2021. PMID: 33547552 Free PMC article.
Individual risk prediction of urinary incontinence after prostatectomy and impact on treatment choice in patients with localized prostate cancer.
Tillier CN, Vromans RD, Boekhout AH, Veerman H, Wollersheim BM, van Muilekom HAM, Boellaard TN, van Leeuwen PJ, van de Poll-Franse LV, van der Poel HG. Tillier CN, et al. Among authors: van leeuwen pj, van de poll franse lv, van der poel hg, van muilekom ham. Neurourol Urodyn. 2021 Aug;40(6):1550-1558. doi: 10.1002/nau.24703. Epub 2021 May 18. Neurourol Urodyn. 2021. PMID: 34004044
222 results